10
Mar

Join Team Jefferson: Komen Race for the Cure

Join the Jefferson Team and Run or Walk In The Fight Against Breast Cancer The Susan G. Komen 25th annual Race for the Cure Philadelphia Museum of Art Mother’s Day, Sunday May 8, 2016 Race Starts at 8:15 AM To register, go to www.komenphiladelphia.org/race and click register now then click join a team and search …

7
Mar

Two forms of radiosurgery for brain metastases are equally effective

With cancer spread to the brain on the rise, patients benefit from advanced techniques, say researchers at Sidney Kimmel Cancer Center (PHILADELPHIA) — While two advanced radiosurgery approaches — Gamma Knife and RapidArc® — offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney Kimmel Cancer Center. Their …

4
Mar

Michael Vido awarded an F30 NIH Fellowship

Michael Vido was recently awarded adn NIH Grant F30 for his project BRAF splice variants in RAF inhibitor resistant melanoma.  Michael is a 4th year MD/PhD student in the lab of Dr. Andrew Aplin, PhD, in the department of Cancer Biology. Melanoma is the leading cause of skin cancer related death and its incidence continues …

3
Mar

Dr. Leonard Gomella featured in Urology

Dr. Leonard Gomella was recently featured in Urology discussing polymorphisms within cell cycle genes and susceptibility to aggressive prostate cancer. The human genome project was completed in 2003 and has opened many new approaches to diagnosing and treating human diseases. This and dozens of similar papers published over the last 10 years have sought to …

2
Mar

Dr. Calabretta & Dr. Mazo receive RO1 Grant: The role of chromatin structure in differentiation of hematopoietic stem cells

Dr Bruno Calabretta & Dr. Alex Mazo were recently awarded an RO1 Grant for their project entitled. The role of chromatin structure in differentiation of hematopoietic stem cells. In this application, Drs Calabretta and Mazo will investigate features of chromatin during cytokine-induced differentiation of hematopoietic stem cells (HSCs) and multipotent (MPPs) CD34+ progenitors.  MPPs possess …

25
Feb

African-American men at higher risk for prostate cancer

African-American men have the highest risk of developing prostate cancer, compared all other races. A study from the Thomas Jefferson University Hospital in Pennsylvania suggests that there are specific genes that may indicate aggressive prostate cancer in African-American men. The researchers believe that their results may partially explain the reason for ethnic disparities in prostate …

23
Feb

Jefferson Partners with SPEAC to create Oral Parity Issue Video

The State Patients Equal Access Coalition (SPEAC) is a patient-focused coalition representing patients, health care professionals, and cancer care centers, working collaboratively to ensure that cancer patients have appropriate access to a broad range of approved and medically-accepted anticancer regimens including, but not limited to oral and intravenous drugs, injections, surgery, radiation, transfusions, transplantation, and …

19
Feb

SKCC Researchers Berger, Mitchell and Pestell featured at Komen Strength & Survival

Pictured above Dr. Adam Berger and Edith Mitchell featured with patients Robin Evans and Sandy Fingerman.  Pictured below Mrs Elaine Grobman CEO of Susan G. Komen, Philadelphia, with Dr. Richard Pestell representing the SKCC at “Strength & Survival: The Universal Language A Musical Celebration of Women!” event which was held on Saturday, February 13th, 2106 at …

10
Feb

PCa agent detects 97% of lesions when paired with PET

In a small study of men with prostate cancer, researchers found a novel agent combined with positron emission tomography (PET) imaging detected 97% of cancerous lesions. The new modality holds promise but will require validation in a larger cohort of patients in one or more separate institutions, one thought leader told Urology Times. The modality, …

9
Feb

Big Ideas in Cancer: A Philadelphia Public Education Event

The event, entitled “Cancer Precision Medicine: Big Ideas in Research, Treatment, and Prevention,” featured six Pennsylvania cancer center directors on a stage together for the first time: AACR President-Elect Nancy Davidson, MD, director of the University of Pittsburgh Cancer Institute, joined Dario Altieri, MD, CEO and director of the Wistar Institute Cancer Center; Chi Dang, …

4
Feb

“Hormone Holiday” Can Improve QoL for Select Patients With Prostate Cancer

   Androgen-deprivation therapy, while an effective treatment for prostate cancer, can result in side effects and a reduced quality of life. Allowing low-risk patients to take breaks between treatments—a practice known as intermittent hormonal therapy, or a “hormone holiday”—may combat these challenges without impacting survival. A recent systematic review and meta-analysis conducted by JAMA Oncology …

3
Feb

Prostate Cancer Lesions Accurately Detected by New Imaging Agent

Thomas Jefferson University researchers recently tested a new imaging technique to detect prostate cancer cells and malignant lesions — a technique they also developed — and report that it is both highly accurate and more effective than current detection methods. Their article, “VPAC1 Targeted 64Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man,” was published in Urology. …

28
Jan

NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

Approximately 79 million people in the United States are currently infected with a human papillomavirus (HPV) according to the Centers for Disease Control and Prevention (CDC), and 14 million new infections occur each year. Several types of high-risk HPV are responsible for the vast majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers. …

Page 1 of 21